Mycobacterium tuberculosis-specific T cell activation identifies individuals at high risk of tuberculosis disease

Cheleka A.M. Mpande; Munyaradzi Musvosvi; Virginie Rozot; Boitumelo Mosito; Timothy D. Reid; Constance Schreuder; Tessa Lloyd; Nicole Bilek; Huang Huang; Gerlinde Obermoser; Mark M. Davis; Morten Ruhwald; Mark Hatherill; Thomas J. Scriba; Elisa Nemes; ACS Study Team

doi:10.1101/2020.06.26.20135665

Mycobacterium tuberculosis-specific T cell activation identifies individuals at high risk of tuberculosis disease

View ORCID ProfileCheleka A.M. Mpande, Munyaradzi Musvosvi, Virginie Rozot, Boitumelo Mosito, Timothy D. Reid, Constance Schreuder, Tessa Lloyd, Nicole Bilek, Huang Huang, Gerlinde Obermoser, Mark M. Davis, Morten Ruhwald, Mark Hatherill, View ORCID ProfileThomas J. Scriba, Elisa Nemes, ACS Study Team

doi: https://doi.org/10.1101/2020.06.26.20135665

Cheleka A.M. Mpande

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Cheleka A.M. Mpande

Munyaradzi Musvosvi

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Virginie Rozot

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Boitumelo Mosito

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Timothy D. Reid

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Constance Schreuder

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tessa Lloyd

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nicole Bilek

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Huang Huang

2Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, United States of America

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gerlinde Obermoser

2Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, United States of America

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark M. Davis

2Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, United States of America

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Morten Ruhwald

3Statens Serum Institut, Copenhagen, Denmark

4Foundation of Innovative New Diagnostics, Geneva, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark Hatherill

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas J. Scriba

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Thomas J. Scriba
For correspondence: elisa.nemes{at}uct.ac.za Thomas.scriba{at}uct.ac.za

Elisa Nemes

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: elisa.nemes{at}uct.ac.za Thomas.scriba{at}uct.ac.za

1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

Data will be available once the pre-print is published in a peer-reviewed journal

View the discussion thread.

PreviousNext

Posted June 29, 2020.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Mycobacterium tuberculosis-specific T cell activation identifies individuals at high risk of tuberculosis disease

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Mycobacterium tuberculosis-specific T cell activation identifies individuals at high risk of tuberculosis disease

Cheleka A.M. Mpande, Munyaradzi Musvosvi, Virginie Rozot, Boitumelo Mosito, Timothy D. Reid, Constance Schreuder, Tessa Lloyd, Nicole Bilek, Huang Huang, Gerlinde Obermoser, Mark M. Davis, Morten Ruhwald, Mark Hatherill, Thomas J. Scriba, Elisa Nemes, ACS Study Team

medRxiv 2020.06.26.20135665; doi: https://doi.org/10.1101/2020.06.26.20135665

Share This Article: